DavidJ.HellersteinMD
Psychiatry • New York, NYPsychopharmacology
Professor of Clinical Psychiatry Columbia University College of Physicians and Surgeons
Dr. Hellerstein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
271 W 70th St
Ste
New York, NY 10023Phone+1 212-875-1357Fax+1 646-774-8034
Summary
- I am a psychiatrist, researcher and writer at Columbia University and the NY State Psychiatric Institute. My research focuses on medication and psychotherapy treatment of chronic depression as well as neuroimaging. My current focus is psychedelic treatments for mood disorders and other conditions.
My literary books include:
The Couch, the Clinic, and the Scanner: Stories from Three Revolutionary Eras of the Mind (Columbia U Press, 2023) https://cup.columbia.edu/book/the-couch-the-clinic-and-the-scanner/9780231207928
and Heal Your Brain: How the New Neuropsychiatry Can Help You Go from Better to Well, published by Johns Hopkins University Press. See: http://www.amazon.com/Heal-Your-Brain-Neuropsychiatry-Better/dp/0801898838/
Education & Training
New York Presbyterian Hospital (Columbia Campus)Fellowship, Consultation-Liaison Psychiatry, 1984 - 1985- New York Presbyterian Hospital (Cornell Campus)Residency, Psychiatry, 1980 - 1984
Stanford University School of MedicineClass of 1980
Certifications & Licensure
NY State Medical License 1981 - 2026- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Abilify as an Adjunctive Treatment for Refractory Depression Start of enrollment: 2005 Mar 01
- Escitalopram in the Treatment of Dysthymic Disorder, Double Blind Start of enrollment: 2002 Jun 01
- Wellbutrin XL for Dysthymic Disorder Start of enrollment: 2004 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- Geographical distance predicts psychiatric treatment retention for Hispanic women with comorbid major depression and breast cancer.Ying Chen, John C Markowitz, Carlos Blanco, Dawn L Hershman, Joy T Zhang
Breast Cancer Research and Treatment. 2024-06-01 - 1 citationsPsilocybin therapy for treatment resistant depression: prediction of clinical outcome by natural language processing.Robert F Dougherty, Patrick Clarke, Merve Atli, Joanna Kuc, Danielle Schlosser
Psychopharmacology. 2023-08-22 - 1 citationsA randomized controlled trial of desvenlafaxine-induced structural brain changes in the treatment of persistent depressive disorder.Ravi Bansal, David J Hellerstein, Siddhant Sawardekar, Ying Chen, Bradley S Peterson
Psychiatry Research. Neuroimaging. 2023-06-01
Journal Articles
- Desvenlafaxine vs. Placebo in the Treatment of Persistent Depressive DisorderDavid Hellerstein, MD, ScienceDirect
Authored Content
- The Couch, the Clinic, and the Scanner: Stories from Three Revolutionary Eras of the MindMay 2023
- Heal Your Brain: How the New Neuropsychiatry can help you go from Better to WellOctober 2011
- A Family of DoctorsFebruary 1994
- Loving TouchesSeptember 1986
- Battles of Life and DeathJanuary 1985
- Join now to see all
Press Mentions
Depression—like Sen. John Fetterman’s—Is Incredibly Common Post-StrokeFebruary 16th, 2023- Antidepressants Don’t Work the Way Many People ThinkNovember 8th, 2022
Serotonin and depressionSeptember 16th, 2022- Join now to see all
External Links
- Depression Evaluation Service, NY State Psychiatric Institutehttps://www.columbiapsychiatry.org/research-clinics/depression-evaluation-service
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
